Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma

Cancer

Volumn 104, Issue 2, 2005, Pages 273-281

  Collins, Veronica ^a,d   Meiser, Bettina ^b,c   Gaff, Clara ^d,e   St John, D James B ^e,f   Halliday, Jane ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f National Cancer Control Initiative   (Australia)

Author keywords

Colonoscopy; Endometrial carcinoma; Genetic testing; Hereditary nonpolyposis colorectal carcinoma; Prospective study; Screening

Indexed keywords

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC SCREENING; HEALTH BEHAVIOR; HETEROZYGOTE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MALE; OVARIECTOMY; OVARY CARCINOMA; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; TRANSVAGINAL ECHOGRAPHY;

ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENITAL NEOPLASMS, FEMALE; HEALTH BEHAVIOR; HETEROZYGOTE; HUMANS; MALE; MUTATION;

EID: 22244459494     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21183     Document Type: Article

References (42)

1. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999;36:801-818.
2. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary non-polyposis colorectal cancer and feasibility of molecular screening for the disease. N Engl J Med. 1998;338: 1481-1487.
3. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996;110:1020-1027.
4. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105-110.
5. Stanley AJ, Gaff CL, Aittomaki AK, Fabre L, Macrae FA, St. John DJB. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC). Med J Aust 2000;172:313-316.
6. Watson P, Narod SA, Fodde R, et al. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. J Med Genet. 2003;40:591-596.
7. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol. 1997;16:63-72.
8. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA. 1996;275:1885-1892.
9. Lodder L, Frets PG, Trijsburg RW, et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet. 2001;98:15-24.
10. Meiser B, Butow P, Friedlander M, et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer. 2002;38:2025-2031.
11. Aktan-Collan K, Haukkala A, Mecklin J-P, Uutela A, Kaariainen H. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer. 2001; 93:608-611.
12. Meiser B, Collins V, Warren R, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC). Clin Genet. 2004;66:502-511.
13. Marteau T, Lerman C. Genetic risk and behavioural change. Br Med J. 2001;322:1056-1059.
14. Lerman C, Hughes C, Croyle RT, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med. 2000;31:75-80.
15. Botkin JR, Smith KR, Croyle RT, et al. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behaviour in women 2 years post testing. Am J Med Genet. 2003;118A:201-209.
16. Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20:1260-1268.
17. Tinley ST, Houfek J, Watson P, et al. Screening adherance in BRCAl 12 families is associated with primary physician's behavior. Am J Med Genet. 2004;125A:5-11.
18. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenteroogyl. 2000;118:829-834.
19. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2004;22:39-44.
20. Ponz de Leon M, Benatti P, Di Gregorio C, et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer. 2004;90: 882-887.
21. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med. 1994;23:142-151.
22. Vernon S. Participation in colorectal-cancer screening: a review. J Natl Cancer Inst. 1997;89:1406-1422.
23. Levin B, Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer. 2002;95: 1618-1628.
24. Peshkin BN, Schwartz MD, Isaacs C, Hughes C, Main D, Lerman C. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomark Prev. 2002;11:1115-1118.
25. Leventhal H, Zimmerman R, Gutmann M. Compliance: a self-regulation perspective. In: Doyle Gentry W, editor. Handbook of behavioral medicine. New York: Guilford-Press, 1984:369-436.
26. Human Genetics Society of Australasia. Guidelines for DNA presymptomatic and predictive testing for genetic disorders. Human Genetics Society of Australasia, 2002. Available from URL: http://www.hgsa.com.au.HCSAPolicies [accessed May 2005].
27. National Health and Medical Research Council. Clinical practice guidelines. The prevention, early detection and management of colorectal cancer. Canberra: National Health and Medical Research Council, 1999.
28. Brown GJE, St. John DJB, Macrae FA, Aittomaki K. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol. 2001;80:346-349.
29. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41:209-218.
30. Thewes B, Meiser B, Hickie IB. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology. 2001;10:459-468.
31. Schoen RE, Weissfeld JL, Trauth JM, Ling BS, Hayran M. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer. Am J Gastroenterol. 2002;97:446-451.
32. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomark Prev. 2000;9:229-232.
33. Michie S, Weinman J, Miller J, Collins V, Halliday J, Marteau TM. Predictive genetic testing: high risk expectations in the face of low risk information. J Behav Med. 2002;25:33-50.
34. Michie S, Smith JA, Senior V, Marteau TM. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet. 2003;119A:340-347.
35. Bleiker EMA, Menko FH, Taal BG, et al. Experience of discharge from colonoscopy of mutation negative HNPCC family members [electronic leter]. J Med Genet. 2003;40:e55.
36. Schwartz MD, Lerman C, Audrain JA. The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med. 1998;20:7-12.
37. Lobb E, Butow P, Tucker K, et al. A communication aid to facilitate risk communication with women from high-risk breast cancer families [abstract]. Psycho-Oncology. 2003;12(4 Suppl);S258.
38. Stoffel EM, Garber JE, Grover S, Russo L, Johnson J, Syngal S. Cancer surveillance is often inadequate in people at high risk for colorectal cancer [electronic letter]. J Med Genet. 2003;40:e54.
39. Tiller K, Meiser B, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. Gynecol Oncol. 2002;86:212-219.
40. Hatcher MB, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. Br Med J. 2001;322:76-79.
41. Meijers-Heijboer H, van Geel B, van Putten WLJ, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345: 159-164.
42. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346:1616-1622.